Ameriprise
ARIA

Ameriprise’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Ameriprise’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,439,502
Closed -$17.9M – 3810
2016
Q4 		$17.9M Buy
1,439,502
+1,120,267
+351% +$13.5M 0.01% 1075
2016
Q3 		$4.37M Buy
319,235
+96,283
+43% +$967K ﹤0.01% 2089
2016
Q2 		$1.65M Sell
222,952
-83,545
-27% -$627K ﹤0.01% 2622
2016
Q1 		$1.96M Sell
306,497
-65,663
-18% -$368K ﹤0.01% 2514
2015
Q4 		$2.33M Sell
372,160
-553,360
-60% -$3.63M ﹤0.01% 2514
2015
Q3 		$5.4M Buy
925,520
+238,110
+35% +$1.83M ﹤0.01% 1957
2015
Q2 		$5.69M Sell
687,410
-396,265
-37% -$3.5M ﹤0.01% 2059
2015
Q1 		$8.93M Sell
1,083,675
-625,960
-37% -$4.63M 0.01% 1646
2014
Q4 		$11.7M Buy
1,709,635
+77,992
+5% +$488K 0.01% 1377
2014
Q3 		$8.81M Buy
1,631,643
+7,398
+0.5% +$43.2K 0.01% 1582
2014
Q2 		$10.3M Buy
1,624,245
+350,740
+28% +$2.41M 0.01% 1504
2014
Q1 		$10.3M Buy
1,273,505
+207,733
+19% +$1.62M 0.01% 1497
2013
Q4 		$7.27M Sell
1,065,772
-4,391,098
-80% -$23.7M ﹤0.01% 1738
2013
Q3 		$100M Buy
5,456,870
+237,573
+5% +$4.61M 0.07% 311
2013
Q2 		$91.3M Buy
+5,219,297
New +$92.5M 0.06% 341

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Ameriprise's ARIA Position: Q1 2017 in Review

Ameriprise sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 1,439,502 shares — an estimated $17.9M sold.

Ameriprise first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $100M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Ameriprise reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Ameriprise sold 1,439,502 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $17.9M.
  • Ameriprise first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • Ameriprise's Ariad Pharmaceuticals Inc position peaked at $100M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Ameriprise's 13F filing for Q1 2017, filed 5 May 2017.